Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound

dc.contributor.authorClark, TA
dc.contributor.authorEdel, AL
dc.contributor.authorHeyliger, CE
dc.contributor.authorPierce, GN
dc.date.accessioned2007-10-09T18:08:48Z
dc.date.available2007-10-09T18:08:48Z
dc.date.issued2004-10-31
dc.description.abstractA novel black tea decoction containing vanadate has successfully replaced insulin in a rat model of insulin-dependent diabetes but is untested in non-insulin-dependent diabetic animals. A tea-vanadate decoction (TV) containing 30 or 40 mg sodium orthovanadate was administered by oral gavage to two groups of Zucker diabetic fatty rats and a conventional water vehicle containing 30 or 40 mg of sodium orthovanadate to two others. In the latter group receiving the 30-mg dose, vanadate induced diarrhea in 50% of the rats and death in 10%. In contrast, TV-treated rats had no incidence of diarrhea and no deaths. Symptoms were more severe in both groups with higher vanadate doses, so these were discontinued. After similar to16 weeks, the level of vanadium in plasma and tissue extracts was negligible in a further group of untreated rats but highly elevated after vanadate treatment. Vanadium levels were not significantly different between the TV-treated diabetic rats and the diabetic rats given vanadate in a water vehicle. Over the 115 days of the study, blood glucose levels increased from similar to17 to 25 mmol/L in untreated diabetic rats. This was effectively lowered (to <10 mmol/L) by TV treatment. Fasting blood glucose levels were 5, 7, and 20 mmol/L in control (nondiabetic, untreated), TV-treated and untreated diabetic rats, respectively. Rats required treatment with TV for only &SIM;50% of the days in the study. Increase in body mass during the study was significantly lower in untreated diabetic rats (despite higher food intake) than the other groups. Body mass gain and food intake were normal in TV-treated rats. Water intake was 28 mL/rat daily in control rats, 130 mL/rat daily in untreated diabetic rats, and 52 mL/rat daily in TV-treated diabetic rats. Plasma creatinine and aspartate aminotransferase levels were significantly depressed in untreated diabetic rats, and TV treatment normalized this. Our results demonstrate that a novel oral therapy containing black tea and vanadate possesses a striking capacity to regulate glucose and attenuates complications in a rat model of type II diabetes.en
dc.format.extent170426 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.citationCAN J PHYSIOL PHARMACOL, OCT 2004, vol. 82, no. 10, p.888 to 894.en
dc.identifier.doihttp://dx.doi.org/10.1139/y04-109
dc.identifier.urihttp://hdl.handle.net/1993/2913
dc.language.isoengen_US
dc.rightsNo part of the NRC Research Press electronic journals may be reproduced, stored, or transmitted in any form or by any means, without the written permission of the publisher, except as stated below. Under the Canadian Copyright Act, individuals may download or print single copies of articles for personal research or study. Any person may reproduce short excerpts from articles in the journals for any purpose that respects the moral rights of authors, provided that the source is fully acknowledged. As a courtesy, the consent of authors of such material should be obtained directly from the author. Authorization to reproduce items for other than personal research or study, as stated above, may be obtained via Access © upon payment of the copyright fee of $10.00 per copy. NRC Research Press also extends certain additional rights to authors. The above rights do not extend to copying or reproduction for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale. For such copying or reproduction, arrangements must be made with NRC Research Press.en
dc.rightsopen accessen_US
dc.statusPeer revieweden
dc.subjectdiabetes mellitusen
dc.subjectteaen
dc.subjectglycemiaen
dc.subjecttype II diabetesen
dc.subjectVANADIUM COMPOUNDSen
dc.subjectMELLITUSen
dc.subjectSULFATEen
dc.subjectGLUCOSEen
dc.subjectBIS(MALTOLATO)OXOVANADIUM(IV)en
dc.subjectDYSFUNCTIONen
dc.subjectMETABOLISMen
dc.subjectMECHANISMSen
dc.subjectAGENTen
dc.subjectSALTSen
dc.titleEffective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compounden
dc.typejournal articleen_US
Files